VectivBio Statistics
Share Statistics
VectivBio has -
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,707 |
| FTD / Avg. Volume | 0.25% |
Short Selling Information
The latest short interest is 168.46K, so 0.27% of the outstanding
shares have been sold short.
| Short Interest | 168.46K |
| Short % of Shares Out | 0.27% |
| Short % of Float | 0.32% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -4.08 and the forward
PE ratio is null.
VectivBio's PEG ratio is
0.12.
| PE Ratio | -4.08 |
| Forward PE | n/a |
| PS Ratio | 13.98 |
| Forward PS | n/a |
| PB Ratio | 1.79 |
| P/FCF Ratio | -6.79 |
| PEG Ratio | 0.12 |
Financial Ratio HistoryEnterprise Valuation
VectivBio has an Enterprise Value (EV) of 171.4M.
| EV / Sales | 6.27 |
| EV / EBITDA | -2.15 |
| EV / EBIT | -3.05 |
| EV / FCF | -3.04 |
Financial Position
The company has a current ratio of 9.14,
with a Debt / Equity ratio of 0.05.
| Current Ratio | 9.14 |
| Quick Ratio | 9.14 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | -0.13 |
| Debt / FCF | -0.19 |
| Interest Coverage | -25.45 |
Financial Efficiency
Return on Equity is -43.93% and Return on Invested Capital is -36.02%.
| Return on Equity | -43.93% |
| Return on Assets | -37.11% |
| Return on Invested Capital | -36.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | undefined |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 107K |
| Effective Tax Rate | -0.11% |
Stock Price Statistics
The stock price has increased by 0.12% in the
last 52 weeks. The beta is 0.1, so VectivBio's
price volatility has been higher than the market average.
| Beta | 0.1 |
| 52-Week Price Change | 0.12% |
| 50-Day Moving Average | 14.67 |
| 200-Day Moving Average | 9.72 |
| Relative Strength Index (RSI) | 67.1 |
| Average Volume (20 Days) | 1,100,434 |
Income Statement
In the last 12 months, VectivBio had revenue of 27.34M
and earned -93.73M
in profits. Earnings per share was -2.12.
| Revenue | 27.34M |
| Gross Profit | 27.34M |
| Operating Income | -80.52M |
| Net Income | -93.73M |
| EBITDA | -79.85M |
| EBIT | -90.46M |
| Earnings Per Share (EPS) | -2.12 |
Full Income StatementBalance Sheet
The company has 221.42M in cash and 10.46M in
debt, giving a net cash position of 210.95M.
| Cash & Cash Equivalents | 221.42M |
| Total Debt | 10.46M |
| Net Cash | 210.95M |
| Retained Earnings | -207.76M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -56.26M
and capital expenditures -74K, giving a free cash flow of -56.33M.
| Operating Cash Flow | -56.26M |
| Capital Expenditures | -74K |
| Free Cash Flow | -56.33M |
| FCF Per Share | -1.28 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of -294.52% and -342.84%.
| Gross Margin | 100% |
| Operating Margin | -294.52% |
| Pretax Margin | -342.45% |
| Profit Margin | -342.84% |
| EBITDA Margin | -292.04% |
| EBIT Margin | -294.52% |
| FCF Margin | -206.04% |
